Boothbay Fund Management’s Envoy Medical COCH Stock Holding History

Boothbay Fund Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-140,886	Closed	-$1.44M	–	1786
2023 Q2	$1.44M	Sell	140,886 -120,000	-46%	-$1.21M	0.03%	678
2023 Q1	$2.62M	Buy	260,886 +144,297	+124%	+$1.45M	0.05%	536
2022 Q4	$1.17M	Buy	116,589 +42,075	+56%	+$418K	0.03%	828
2022 Q3	$732K	Hold	74,514	–	–	0.02%	1035
2022 Q2	$730K	Hold	74,514	–	–	0.02%	966
2022 Q1	$728K	Hold	74,514	–	–	0.02%	1094
2021 Q4	$726K	Hold	74,514	–	–	0.02%	879
2021 Q3	$724K	Hold	74,514	–	–	0.02%	909
2021 Q2	$725K	Buy	+74,514	New	+$724K	0.02%	835

Other funds holding COCH

AMC

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Boothbay Fund Management's COCH Position: Q3 2023 in Review

Boothbay Fund Management sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 140,886 shares — an estimated $1.44M sold.

Boothbay Fund Management first reported a position in COCH in Q2 2021 and held it in 9 quarters. The position peaked at $2.62M in Q1 2023. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

Boothbay Fund Management reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 140,886 Envoy Medical shares in Q3 2023, an estimated $1.44M.
Boothbay Fund Management first reported a position in Envoy Medical in Q2 2021 and held it in 9 quarters.
Boothbay Fund Management's Envoy Medical position peaked at $2.62M in Q1 2023.
16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.